Filing Details

Accession Number:
0001140361-10-042362
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-27 11:58:03
Reporting Period:
2010-10-25
Filing Date:
2010-10-27
Accepted Time:
2010-10-27 11:58:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1301173 H Jeffrey Cooper C/O Biomarin Pharmaceutical Inc.
10 Digital Drive
Novato CA 94949
Svp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-10-25 1,459 $5.15 27,945 No 4 M Direct
Common Stock Acquisiton 2010-10-25 13,750 $6.13 41,695 No 4 M Direct
Common Stock Disposition 2010-10-25 15,209 $24.00 26,486 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2010-10-25 1,459 $0.00 1,459 $5.15
Common Stock Stock Option (right to buy) Acquisiton 2010-10-25 13,750 $0.00 13,750 $6.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
356,500 2005-02-19 2014-08-18 No 4 M Direct
342,750 2005-07-07 2015-01-07 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a Rule 10b5-1 Trading plan execued on March 9, 2010.
  2. Original option grant vested 6/48ths on February 19, 2005 and 1/48th on the 19th of every month thereafter.
  3. Original option grant vested 6/48ths on July 7, 2005 and 1/48th on the 7th of every month thereafter.